Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (Monomer, MALS verified)

CAT:
716-HLV-H82E6-200ug
Size:
200µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (Monomer, MALS verified) - image 1

Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (Monomer, MALS verified)

  • Background:

    The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Human HLA-A*1101 KRASG12V (VVGAVGVGK) complex protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and VVGAVGVGK peptide of the KRASG12V.
  • Description:

    Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (HLV-H82E6) is expressed from human 293 cells (HEK293) . It contains AA Gly 25 - Thr 305 (HLA-A*11:01) & Ile 21 - Met 119 (B2M) & VVGAVGVGK peptide (Accession # Q5S3G3-1 (HLA-A*11:01) & P61769 (B2M) & VVGAVGVGK) .
  • Specifications:

    Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein is produced by co-expression of HLA and B2M loaded with KRASG12V peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™) . The protein has a calculated MW of 36.0 kDa and 11.7 kDa. The protein migrates as 40-45 kDa and 12 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
  • Accession Number:

    Q5S3G3-1 (HLA-A*11:01) & P61769 (B2M) & VVGAVGVGK
  • Expression Region:

    Gly 25 - Thr 305 (HLA-A*11:01) & Ile 21 - Met 119 (B2M) & VVGAVGVGK peptide
  • Host:

    HEK293
  • Target:

    HLA-A*1101 | B2M | KRASG12V (VVGAVGVGK)
  • Conjugation:

    Biotin-labeled
  • Tag:

    C-10xHis & C-Avi
  • Source:

    Human
  • Stability:

    ● -20°C to -70°C for 12 months in lyophilized state; ● -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.
  • Endotoxin:

    1.0 EU per μg
  • Purity:

    90%
  • Bioactivity:

    Immobilized Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (Cat. No. HLV-H82E6) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.1-2 ng/mL (QC tested).
  • Format:

    Powder
  • Buffer:

    PBS, pH7.4
  • Additives:

    Trehalose
  • Molecular Weight:

    36.0 kDa and 11.7 kDa
  • Shipping Conditions:

    RT
  • Storage Conditions:

    -20°C
  • Package Size:

    100ug*2
  • Species:

    Human